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INTRODUCTION
Chronic venous ulcers (CVUs) are one of the main public health problems in Identification of potential biomarkers present in exudate from CVUs can aid 47 in comprehending the processes in the success or failure of healing and in the de-48 velopment of new therapeutic alternatives [19, 22] , as well as predicting the lesion 49 chronicity prognosis. The present work aimed to identify potential proteins differen-50 tially expressed in inflammatory exudate from CVUs, and correlate them with the 51 evolution of the healing process, in order to differentiate healing and no-healing Brazil, presenting one or more active CVUs with diameter from two to 15 cm and 63 with evolution greater than six weeks. Patients with ulcers of another etiology, as-64 sociated with peripheral arterial disease (confirmed through vascular Doppler ultra-area of each lesion from the resolution (pixels/cm) of each ulcer. The ulcer area at 95 T=0 (A0) was utilized as a reference to determine the diminution or lack thereof of 96 the wound at T=90 (A90) by the equation ΔA=A90-A0. The difference between the 97 initial and final areas of each ulcer was denominated the ulcer reduction velocity. tient was maintained at rest for 30 to 60 minutes to wait for natural exudation. The 107 exudate accumulated between the bedding of the ulcer and the dressing was col-108 lected with the aid of a disposable-tip micropipette, and then transferred to Eppen-acetonitrile in 0.1% (v / v) formic acid over 60 minutes at the flow rate of 600 143 nL/min. The instrument was operated in positive ionization mode and continuous 144 data acquisition was obtained in the molecular mass range from 100 to 2,000 m/z. proteins were quantified with the requirement that at least two peptides be in 163 common in the samples.
SDS-PAGE and Western blotting 167
The experiments were performed according to the methodology described Those proteins that were present in at least 90% of the ulcers studied were considered prognostic molecular marker can-proteins Apoliprotein A1 and Neutrophil-defensin-1 presented differential expres-239 sion in ulcers that did not heal or increased their initial area across the 90 days.
240
The identification data of these proteins are displayed in Table 2 . 241 In contrast to the evidence indicated by mass spectrometry analyses, west- 4 † -ulcers that did not present area reduction at T=90 Antimicrobial activity NH * H: differential expression in CVUs that had area reduction; NH: differential expression in CVUs that did not present reduction.
